Surrozen Inc (SRZN)
9.89
-0.87
(-8.09%)
USD |
NASDAQ |
May 01, 16:00
9.61
-0.28
(-2.83%)
After-Hours: 20:00
Surrozen Price to Book Value: 0.834 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 01, 2024 | 0.834 |
April 30, 2024 | 0.9073 |
April 29, 2024 | 0.7834 |
April 26, 2024 | 0.7572 |
April 25, 2024 | 0.726 |
April 24, 2024 | 0.7564 |
April 23, 2024 | 0.7598 |
April 22, 2024 | 0.78 |
April 19, 2024 | 0.7931 |
April 18, 2024 | 0.7867 |
April 17, 2024 | 0.7893 |
April 16, 2024 | 0.7859 |
April 15, 2024 | 0.8222 |
April 12, 2024 | 0.9048 |
April 11, 2024 | 0.9347 |
April 10, 2024 | 0.9284 |
April 09, 2024 | 0.9571 |
April 08, 2024 | 0.9469 |
April 05, 2024 | 0.6181 |
April 04, 2024 | 0.6292 |
April 03, 2024 | 0.5965 |
April 02, 2024 | 0.5259 |
April 01, 2024 | 0.5609 |
March 28, 2024 | 0.8543 |
March 27, 2024 | 0.7792 |
Date | Value |
---|---|
March 26, 2024 | 0.7423 |
March 25, 2024 | 0.7385 |
March 22, 2024 | 0.7505 |
March 21, 2024 | 0.751 |
March 20, 2024 | 0.775 |
March 19, 2024 | 0.7173 |
March 18, 2024 | 0.7246 |
March 15, 2024 | 0.6956 |
March 14, 2024 | 0.7342 |
March 13, 2024 | 0.7222 |
March 12, 2024 | 0.7287 |
March 11, 2024 | 0.7244 |
March 08, 2024 | 0.726 |
March 07, 2024 | 0.7342 |
March 06, 2024 | 0.7369 |
March 05, 2024 | 0.7349 |
March 04, 2024 | 0.7287 |
March 01, 2024 | 0.7206 |
February 29, 2024 | 0.707 |
February 28, 2024 | 0.7342 |
February 27, 2024 | 0.6781 |
February 26, 2024 | 0.6455 |
February 23, 2024 | 0.6781 |
February 22, 2024 | 0.695 |
February 21, 2024 | 0.745 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.1705
Minimum
Dec 16 2022
8.910
Maximum
Sep 16 2021
1.076
Average
0.7346
Median
Price to Book Value Benchmarks
CEL-SCI Corp | 6.059 |
AIM ImmunoTech Inc | 2.039 |
IGC Pharma Inc | 3.576 |
NovaBay Pharmaceuticals Inc | 1.968 |
Protalix BioTherapeutics Inc | 2.633 |
Price to Book Value Related Metrics
Price | 9.89 |
Earnings Yield | -215.7% |
Market Cap | 31.64M |